Page last updated: 2024-09-03

imatinib mesylate and Adrenal Cortex Cancer

imatinib mesylate has been researched along with Adrenal Cortex Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Faucz, FR; Nadella, K; Stratakis, CA	1

Other Studies

1 other study(ies) available for imatinib mesylate and Adrenal Cortex Cancer

Article	Year
c-KIT oncogene expression in PRKAR1A-mutant adrenal cortex. Endocrine-related cancer, 2020, Volume: 27, Issue:10 Topics: Adrenal Cortex Neoplasms; Animals; Antineoplastic Agents; Cell Line, Tumor; Cyclic AMP-Dependent Protein Kinase RIalpha Subunit; Female; Humans; Imatinib Mesylate; Mice; Mice, Nude; Oncogenes; Proto-Oncogene Proteins c-kit; Random Allocation; Transfection; Xenograft Model Antitumor Assays	2020

Article

Year

c-KIT oncogene expression in PRKAR1A-mutant adrenal cortex.

Endocrine-related cancer, 2020, Volume: 27, Issue:10

Topics: Adrenal Cortex Neoplasms; Animals; Antineoplastic Agents; Cell Line, Tumor; Cyclic AMP-Dependent Protein Kinase RIalpha Subunit; Female; Humans; Imatinib Mesylate; Mice; Mice, Nude; Oncogenes; Proto-Oncogene Proteins c-kit; Random Allocation; Transfection; Xenograft Model Antitumor Assays

2020